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The exocyst complex plays a critical role in targeting
and tethering vesicles to specific sites of the plasma
membrane. These events are crucial for polarized
delivery of membrane components to the cell sur-
face, which is critical for cell motility and division.
Though Rho GTPases are involved in regulating actin
dynamics and membrane trafficking, their role in
exocyst-mediated vesicle targeting is not very clear.
Herein, we present evidence that depletion of GEF-
H1, a guanine nucleotide exchange factor for Rho
proteins, affects vesicle trafficking. Interestingly, we
found that GEF-H1 directly binds to exocyst compo-
nent Sec5 in a Ral GTPase-dependent manner. This
interaction promotes RhoA activation, which then
regulates exocyst assembly/localization and exocy-
tosis. Taken together, our work defines amechanism
for RhoA activation in response to RalA-Sec5 sig-
naling and involvement of GEF-H1/RhoA pathway in
the regulation of vesicle trafficking.
INTRODUCTION
Membrane trafficking is crucial for delivery of specificmembrane
and protein components to defined sites on the cell surface
during cell division, migration, and secretion (Caswell and
Norman, 2008; Montagnac et al., 2008). The polarized
membrane delivery in many cell types is regulated by an evolu-
tionarily conserved protein complex, termed ‘‘exocyst’’ which
comprises eight proteins, Sec3, 5, 6, 8, 10, and 15 and Exo70
and 84. The exocyst is a dynamic complex assembled from
subunits that form a targeting patch on the plasma membrane
(PM) and a vesicle-associated subcomplex, which function
together to both target and tether vesicles to specific sites of
the dynamic PM (He and Guo, 2009). The exocyst plays impor-
tant roles in targeting membrane to the expanding leading
edge, as well as adhesion and signaling molecules necessary
for motility and chemotaxis. Exocyst components are also
involved in several endocytic pathways in polarized MDCK
cells (Oztan et al., 2007). Furthermore, exocyst proteins interact
with the recycling endosomes as well as exocytic vesiclesDevelopto regulate their tethering at the cleavage furrow to drive
abscission during cytokinesis (Fielding et al., 2005; Gromley
et al., 2005).
Small GTPases of the Rab, Arf, and Ral families have been
implicated as important spatiotemporal regulators of membrane
trafficking events by the exocyst (Novick and Guo, 2002; Prigent
et al., 2003). Studies done in yeast implicate RhoGTPases also in
regulation of exocyst function (Guo et al., 2001). However, the
role of mammalian Rho GTPases in exocyst-mediated vesicle
targeting is not very clear. A key event for the spatiotemporal
regulation of Rho GTPases is their localized activation by the
guanine nucleotide exchange factors (GEFs), which promote
the exchange of GDP with GTP by Rho GTPases.
GEF-H1, a member of the Dbl family of GEFs, activates Rho
GTPases (RhoA, B, and C) (Krendel et al., 2002; Ren et al.,
1998). Catalytic activity of GEF-H1 is uniquely regulated by its
localization to the microtubules (MTs). MT depolymerization
leads to GEF-H1 activation, while relocalization to MT inhibits
its activity (Krendel et al., 2002). Thus, in a number of biological
systems, the stimulus-induced disassembly of MT leads to
GEF-H1 mediated spatiotemporal activation of RhoA, e.g., at
the cleavage furrow during cytokinesis, and during cell motility
(Birkenfeld et al., 2007, 2008; Nalbant et al., 2009). Interestingly,
in our previous studies, we observed that depletion of GEF-H1
caused aberrant cleavage furrow formation that results in failure
of cytokinesis (Birkenfeld et al., 2007) and accumulation of vesi-
cles at the cleavage site indicative of disruption in vesicular
traffic. Cells depleted in GEF-H1 also showed defects in both
actin dynamics and focal adhesion turnover at the leading
edge resulting in a significant defect in cell migration (Nalbant
et al., 2009). These defects are dependent on the ability of
GEF-H1 to activate Rho GTPase.
In the current study, we have identified the involvement of Rho
activating factor GEF-H1 in the regulation of vesicles trafficking
pathways of endocytic recycling and exocytosis. We show that
GEF-H1 interacts directly with Sec5, a component of exocyst
complex, and affects the assembly and/or stability of an exocyst
subcomplex and localization of the exocyst components in
a GEF-H1 activity-dependent manner. We further report that
RalA, a critical regulator of vesicle trafficking, stimulates the
interaction between GEF-H1 and Sec5, which, in turn, is respon-
sible for RhoA activation. Finally, we show that RhoA also plays
a direct role in the process of exocytic trafficking by regulating
assembly or maintenance of exocyst subcomplex andmental Cell 23, 397–411, August 14, 2012 ª2012 Elsevier Inc. 397
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a mechanism for RhoA activation in response to RalA-Sec5
signaling and a function for GEF-H1/RhoA pathway in the
regulation of vesicle trafficking.
RESULTS
Perturbation ofGEF-H1 Function Leads toAccumulation
of Vesicular Structures
To determine if the role of GEF-H1 in membrane traffic is not just
confined to cytokinesis as observed previously (Birkenfeld et al.,
2007), we examined the phenotype of control and GEF-H1-
depleted cells in nonmitotic phases. Two GEF-H1-targeting
small interfering RNA (siRNA) oligonucleotides were used, both
of which reduced cellular GEF-H1 levels significantly (Figure S1
available online). The vesicular traffic observed by time-lapse
microscopy using differential interference contrast (DIC) micros-
copy showed that loss of GEF-H1 led to accumulation of vesic-
ular structures in the cells (Figures 1A and 1B; 73% and 60% of
cells treated with oligos #8 and #9, respectively, Movies S1, S2,
and S3). The phenotype was rescued by expression of siRNA-
resistant wild-type protein but not by expression of siRNA-resis-
tant GEF-H1 variant with mutation (Y393A) in the DH domain that
abolishes GEF-H1 nucleotide exchange activity (Krendel et al.,
2002) (Figures 1C and 1D). To rule out the possibility of pheno-
type being the result of formation of membrane blebs instead
of disruption in vesicular traffic, we performed thin layer electron
microscopy. Accumulation of heterogeneous population of
vesicles was observed in 86% of GEF-H1 knockdown cells
compared to 17% of control cells (Figure 1E), further confirming
the role of GEF-H1 in vesicle trafficking. Therefore, all these
results combined suggest a crucial role of GEF-H1 activity in
membrane trafficking.
GEF-H1 Depletion Leads to Accumulation
of Rab11-Positive Vesicles
Our results suggest that accumulation of vesicles in GEF-H1-
depleted cells could be due to a defect in membrane transport
mechanism such as endocytic pathway, including endocytosis
and endocytic recycling (Maxfield and McGraw, 2004; Mellman,
1996). To test this hypothesis, we examined the subcellular
localization of various proteins that localize to vesicles at
different stages of endocytic pathway such as EEA1, an early en-
dosome antigen 1 protein; Rab7, a late endosome protein;
LAMP1, a lysosome protein; and Rab11, a recycling endosome
and a post-Golgi protein marker (Feng et al., 1995; Kornfeld
and Mellman, 1989; Stenmark et al., 1996; Ullrich et al., 1996;
Urbe´ et al., 1993). Control and GEF-H1-depleted cells were
immunostained for the above-mentioned proteins. In control
cells, Rab11 localized primarily in a single discreet patch in the
perinuclear region that corresponds to the endocytic recycling
compartment (ERC) and a few small punctas throughout the
cytoplasm (Figure 2A). Interestingly, in GEF-H1-ablated cells,
the Rab11 fluorescence associated with small vesicles outside
the ERC was enhanced by 2-fold (Figures 2A and 2B) compared
to control siRNA cells, whereas localization of Rab11 to the ERC
was not affected. We did not observe any difference in the local-
ization of EEA1, Rab7, and Lamp1 between control andGEF-H1-
knockdown cells (data not shown). These results indicate that398 Developmental Cell 23, 397–411, August 14, 2012 ª2012 Elseviea subpopulation of vesicles in GEF-H1-depleted cells could be
recycling endosomes or post-Golgi vesicles.
GEF-H1 Depletion Affects Localization and the
Recycling of Transferrin
Mis-localization of Rab11 prompted us to study endocytosis and
endocytic recycling in GEF-H1-depleted cells to determine
whether GEF-H1 plays a role in either receptor internalization
and/or recycling. Control and GEF-H1-depleted cells were incu-
bated with fluorescently labeled transferrin (Tfn) for 10 min to
observe ligand internalization. In control cells, the majority of
Tfn was found associated with the ERC, with some distributed
throughout the cytoplasm (Figure 2C). In GEF-H1-depleted cells,
there was 1.5-fold more Tfn scattered throughout the cytoplasm
and at the cell periphery compared to control cells (arrow head in
Figure 2C). These data suggest that GEF-H1 depletion might
increase the uptake and/or diminish the recycling of transferrin
receptors (TfR). To test this hypothesis, we first performed
kinetic analysis of Tfn uptake (Sever et al., 2000). Cells were incu-
bated with the biotinylated-Tfn, samples were taken out at
different time points and the sequestration of Tfn was measured
as the amount that remains inaccessible to exogenously added
avidin (which masks surface bound biotinylated Tfn). We did not
observe any difference in the initial Tfn uptake between the
control and GEF-H1-depleted cells (Figure 2D). However, sus-
tained uptake after 10 min led to a gradual decrease in the inter-
nalization of the ligand in GEF-H1-depleted cells (Figure 2D). It is
possible that during the later time points the uptake is diminished
in the absence of GEF-H1 due to a defect in recycling of TfR to
the cell surface for uptake of fresh ligand.
We next analyzed the effect of GEF-H1 depletion on recycling
of TfR by using fluorescently labeled Tfn and measuring the
kinetics of recycling by fluorescence microscopy. GEF-H1
depletion resulted in the dispersed localization of Tfn after
60 min of steady uptake with incorporation of the ligand in the
larger vesicles visible in DIC (e.g., arrow head in Figure 2E). In
contrast, in control cells Tfn was predominantly perinuclear
(Figure 2E). Furthermore, we observed a slight delay in recycling
of receptors to the surface in GEF-H1-depleted cells with a half
life of 21.3 ± 1.2 min compared to 17.3 ± 2.3 min for control cells
(Figure 2F). These data are statistically significant (p value of 0.05
as calculated by two-tailed Student’s t test). Our results indicate
a defect in localization of Tfn and a slight delay in recycling
through the ERC in absence of GEF-H1.
GEF-H1 Regulates Exocytic Pathway
To gain further information into the involvement of GEF-H1 in
membrane trafficking pathways, we next investigated its role in
the process of exocytosis by using the secretory reporter vesic-
ular stomatitis virus temperature-sensitive variant ts045 (GFP-
VSV-Gts045). At restrictive temperature VSV-Gts045 is retained
within the ER, then upon shift to permissive temperature moves
as a synchronous population through the Golgi to the PM
(Hirschberg et al., 1998). We used GFP-VSV-G to visualize its
transport within the cells, while incorporation into the PM was
detected by immunostaining with 8G5 monoclonal antibody
against the extracellular domain of the protein, without permea-
bilization (Lefrancois and Lyles, 1982). GFP fluorescence re-
vealed that most of VSV-G protein was localized in the Golgir Inc.
Figure 1. Perturbation of GEF-H1 Function Leads to Accumulation of Vesicular Structures
(A) HeLa cells were transfected with either control siRNA or two different GEF-H1 specific oligonucleotide siRNA (#8 and #9). After 72 hr, the cells were visualized
using DIC. Scale bar, 10 mm. See also Movies S1, S2, and S3.
(B) Percentage of cells showing accumulation of vesicles of varying sizes is shown for the control and GEF-H1-knockdown cells. Data represent means ± SD for
approximately 80 cells/sample and results from three separate experiments are shown. Significance values were evaluated using two-tailed Student’s t test
(***p < 0.0005).
(C) Cells were transfected with GEF-H1 specific siRNA (oligo #9) to deplete the endogenous protein. After 48 hr, depleted cells were transfected with siRNA
resistant GEF-H1wt or catalytically inactive mutant (GEF-H1Y393A). Proteins were allowed to express for 20 hr, and then cells were visualized under DIC (vesicles
indicated by an arrowhead). Scale bar, 10 mm.
(D) The percentage of cells showing the accumulation of vesicles was calculated. More than 50 cells were analyzed for each sample. Data represent means ± SD
from three independent experiments. Significance values were evaluated using two-tailed Student’s t tests (**p < 0.005, ***p < 0.0005).
(E) HeLa cells plated on plastic bottom dishes were transfected with control or GEF-H1 siRNA. Seventy-two hours posttransfection, cells were processed using
the Gilula et al. method (Gilula et al., 1978) and visualized using electron microscope (arrows represent vesicles).
See also Figure S1 and Movies S1, S2, and S3.
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Figure 2. Depletion of GEF-H1 Leads to Accumulation of Rab11-Positive Vesicles and Affects Localization and Recycling of Transferrin
(A) Control and GEF-H1-depleted cells were immunostained for Rab11. Cells were then visualized by fluorescence microscopy. Scale bar, 10 mm.
(B) The fluorescence intensity associated with Rab11 outside the perinuclear endocytic recycling compartment was quantified and expressed relative to
the control. More than 60 cells were used to quantify the fluorescence intensity and results for three independent experiments are shown. Data represent
means ± SD. Significance values were calculated using two-tailed Student’s t test (*p < 0.05).
(C) Control and GEF-H1-depleted cells were incubated with Alexa 568 labeled transferrin for 10 min. Cells were then subjected to a brief acid wash to remove
surface bound Tfn, fixed, and visualized under fluorescence microscope.
(D) Kinetics of Tfn uptake was measured for control and GEF-H1-depleted cells as described in Experimental Procedures. A representative plot, of four inde-
pendent experiments is shown.
(E) To study the effect of GEF-H1 depletion on Tfn recycling, the cells were incubated with labeled Tfn for 1 hr; this is the first time point (0 min). Most of the
fluorescence in the control cells is associated with ERC and small endocytic vesicles. In GEF-H1-depleted cells besides localization to the ERC a significant
fraction was contained within large vesicles (marked by an arrowhead).
(F) After washing out the labeled Tfn, cells were incubated with excess of unlabeled Tfn to enable recycling. Samples were taken out at different time points,
subjected to acid wash, fixed, and visualized by fluorescence microscopy. The fluorescence intensity associated with each cell was quantified and expressed as
percentage of the intensity at time point 0 min. Representative graph from three different experiments is shown.
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control and GEF-H1-depleted cells indicating that trafficking
from ER to Golgi was not affected by GEF-H1 depletion (Fig-
ure 3A). Interestingly, we observed a 2-fold less insertion of
VSV-G at the PM in GEF-H1-depleted cells compared to control
cells indicating a delay in the transport fromGolgi to the PM (time
points 60–90 min) (Figures 3A and 3B). These results suggest
a positive role for GEF-H1 in regulation of exocytosis.
To further investigate this possibility, we examined the effect
of GEF-H1 (wt, microtubule binding-deficient variant (C53R)
that is constitutively active (Krendel et al., 2002), and inactive
Y393A variant) overexpression on GFP-VSV-G ts045 trafficking.
We observed that in all conditions VSV-G transport from ER to
Golgi was not affected (Figure 3C, time point 30 min). However,
cells overexpressing GEF-H1wt showed an increase of VSV-G at
the PM (Figures 3C and 3D; 35% more fluorescence intensity of
8G5 at the PM after 60 min compared to empty vector control
cells). Expression of GEF-H1C53R led to a further increase in
the appearance of VSV-G on the surface (up to 55% more fluo-
rescence intensity compared to empty vector control cells)
(Figures 3C and 3D). In contrast, overexpression GEF-H1Y393A
mutant caused a decrease in the insertion of VSV-G protein at
the PM by 20% as compared to control cells (Figures 3C and
3D). Therefore, we conclude that GEF-H1 exerts a positive influ-
ence on VSV-G trafficking from Golgi to PM through its catalytic
activity. Together, these results demonstrate that GEF-H1 is
involved in both endocytic recycling and exocytosis.
GEF-H1 Depletion Perturbs the Localization of Exocyst
Components Exo70 and Sec8 and Affects the Complex
Assembly/Stability
Since the defect in GEF-H1 activity leads to disruption of both
endocytic recycling and exocytosis, we hypothesized that
GEF-H1 might control the later stages of membrane trafficking.
The exocyst complex plays a crucial role in tethering and fusion
of vesicles at the PM and disruption of its function leads to
defects in secretion and accumulation of vesicles (He and Guo,
2009; Wu et al., 2008). Therefore, we decided to investigate
the possibility that disruption in vesicle trafficking in the absence
of GEF-H1 could be associated with exocyst function. To test
this hypothesis, we examined the localization of exocyst compo-
nents in GEF-H1-depleted cells. Due to the availability of anti-
bodies, we determined the localization of exocyst protein
Exo70 in control and GEF-H1-depleted cells. In control cells,
Exo70 localized both at the PM and on vesicular structures in
the cytoplasm (Figure 4A) similar to what was observed in yeast
(Boyd et al., 2004). Interestingly, we observed an increase in the
accumulation of Exo70-positive vesicles at the periphery of GEF-
H1-ablated cells (Figure 4A). Quantification of the number of
vesicles/cell revealed that 50% of GEF-H1-depleted cells have
more than 40 vesicles/cell compared to only 10% of control cells
(Figure 4B). Since Exo70 has been suggested to serve as the
docking point for assembly of the complete exocyst complex
at the membrane (Liu et al., 2007), we examined the localization
of Sec8, another component of exocyst complex. We observed
that in control cells, more than 70% of cells exhibited Sec8
localization to both the cell leading edge and cytoplasm,
whereas in GEF-H1-depleted cells, only 30% of cells showed
Sec8 localization to the cell edge (Figures 4C and 4D). The lossDevelopof Sec8 PM localization was not due to the differences in
membrane morphology between control and GEF-H1-depleted
cells as distribution of membrane protein Na+K+ATPase was
not altered by GEF-H1 ablation (Figure S2). We also observed
a more dispersed localization of Sec8 in GEF-H1-depleted cells
as compared to control cells (Figure 4C). These data indicate that
the loss of GEF-H1 perturbs Exo70 and subsequently Sec8
localization.
Studies done in yeast suggest that the formation of a complex
between components present on vesicles with the rest of exo-
cyst constituents at the PM is critical for directing vesicle traffic
(Guo et al., 2000). Therefore, we examined the effect of GEF-H1
expression constructs (GEF-H1wt, Y393A (constitutively inactive)
or C53R (constitutively active)) on assembly of such a subcom-
plex between Sec8 and Exo70 in immunoprecipitation experi-
ments. Immunoblot analysis of the precipitation of endogenous
Sec8 revealed that overexpression of GEF-H1wt led to a signifi-
cant increase in association between Sec8 and Exo70 proteins
compared to cells expressing empty vector; this effect was
further enhanced by expression of GEF-H1C53R variant (Figures
4E and 4F). Interestingly, the association between Sec8 and
Exo70 was reduced by approximately 40% in cells expressing
inactiveGEF-H1Y393A variant when compared to cells with empty
vector (Figures 4E and 4F). Thus, together, these results strongly
support a role of GEF-H1 activity in regulating the localization of
exocyst proteins to the PM and the complex assembly and/or
stability.
GEF-H1 Interacts Directly with Exocyst Protein Sec5
We identified an interaction between GEF-H1 and exocyst using
mass spectrometry analysis. We confirmed the interaction
between GEF-H1 and Sec5 by pull-down experiments in HeLa
cells coexpressing EGFP-GEF-H1 and HA-Sec5 (Figure 5A). To
determine the region of GEF-H1 that binds to Sec5, we used
a panel of recombinant purified truncated glutathione S-trans-
ferase (GST)-GEF-H1 mutants, (described in Figure 5B, bottom
panel) and performed GST pull-down assays with lysates from
HeLa cells expressing HA-Sec5. We found that the C-terminal
constructs (462–570 and 572–985 constructs 3 and 4, Figure 5B,
lane 4 and 5, respectively) failed to interact with HA-Sec5 while
the N-terminal constructs (1–236 and 237–467 constructs 1
and 2, respectively) demonstrated interactionwith HA-Sec5 (Fig-
ure 5B, lane 2 and 3, respectively). We further mapped the region
of GEF-H1 interacting with Sec5 by using shorter N-terminal
regions of GEF-H1 (Figure 5B, constructs 5–9, lanes 6–10).
Constructs 10 and 11 (amino acids 200–236 and 220–250,
respectively) did not interact with HA-Sec5 (Figure 5B, lanes 11
and 12), while construct 9 (amino acids 119–236) coprecipitated
efficiently with HA-Sec5 (Figure 5B, lane 10). These data indicate
that the critical Sec5-binding region of GEF-H1 is within amino
acid residues 119–200. We next determined whether GEF-H1
could directly interact with Sec5. Since Sec5 is a high molecular
weight protein, it is difficult to express in Escherichia coli; thus,
we produced HA-Sec5 protein using the Promega TNT-T7
in vitro reticulocyte lysate expression system.We then incubated
the in-vitro-translated HA-Sec5 protein with purified GST or GST
tagged fragments of GEF-H1 (described in Figure 5C, bottom
panel) and assayed for coprecipitation between Sec5 and GST
proteins by GST pull-down. As shown in Figure 5C, onlymental Cell 23, 397–411, August 14, 2012 ª2012 Elsevier Inc. 401
Figure 3. GEF-H1 Is Involved in Exocytic Trafficking of VSV-G
(A) Cells were transfected with control or GEF-H1 specific siRNA. After 48 hr, the cells were transfected again with GFP-VSV-G and immediately transferred to
40C for 20 hr. After removing the first sample (0 min), cells were shifted to 32C. Samples were then taken at 30, 60, and 90 min posttemperature shift, fixed, and
immunostained with 8G5 antibody without permeabilization and observed using confocal microscope. Scale bar, 10 mm.
(B) Fluorescence intensity associated with 8G5 staining of GEF-H1-depleted cells at time points 60 and 90 min was quantified and expressed relative to control
cells. More than 80 cells were quantified for each sample and results of three independent experiments are plotted. Data represent means ± SD. Significance
values were calculated using two-tailed Student’s t test (***p < 0.0005).
(C) VSV-G trafficking assay was performed with cells cotransfected with GFP-VSV-G and empty vector, HA-GEF-H1wt, GEF-H1Y393A, and GEF-H1C53R as
described earlier. Scale bar, 10 mm.
(D) Fluorescence intensity associatedwith 8G5 staining of the samples at time points 60 and 80minwas quantified and expressed relative to cells transfectedwith
empty vector. More than 60 cells were quantified for each sample and results of three independent experiments are plotted. Data represent means ± SD.
Significance values were calculated using two-tailed Student’s t test (*p < 0.05).
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Figure 4. GEF-H1DepletionPerturbsLocalizationof ExocystComponents Exo70andSec8, aswell asAssembly/Stability of ExocystComplex
(A) Control and GEF-H1-depleted cells were immunostained for endogenous Exo70. The white boxes are enlarged in the bottom panel to show, in detail, features
of Exo70 localization at/near the PM. Scale bar, 10 mm.
(B) Number of Exo70-positive vesicles in control and GEF-H1-depleted cells were counted and the percentage of cells carrying indicated number of vesicles/cell
were plotted. More than 50 cells were analyzed from three separate experiments. Data represent means ± SD. Significance values were calculated using two-
tailed Student’s t test (**p < 0.005).
(C) Immunostaining of cells transfected with either control or GEF-H1-specific siRNA with a-Sec8 antibody. Scale bar, 10 mm.
(D) Percentage of cells exhibiting leading edge localization of endogenous Sec8 in control and GEF-H1-depleted cells was plotted. Data represent means ± SD.
Significance values were calculated using two-tailed Student’s t test (**p < 0.005).
(E) Lysates from cells transfected with empty vector, GEF-H1wt, GEF-H1Y393A, or GEF-H1C53R were subjected to immunoprecipitation (IP) with a-Sec8 antibody
and the blots were then probed with a-Exo70 antibodies. The western blot against actin was used to show equal loading.
(F) The band intensities were quantified using Image J software and the amount of Exo70 pulled down from each sample was normalized to the levels of
precipitated Sec8 and expressed relative to the sample transfected with empty vector. Data represent means ± SD. Significance values were calculated using
two-tailed Student’s t test (*p < 0.05).
See also Figure S2.
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Figure 5. GEF-H1 Interacts with Exocyst Protein Sec5
(A) EGFP-GEF-H1 and HA-Sec5 were coexpressed in HeLa cells. HA-Sec5 was then IPed using a-HA antibody and probed for coprecipitation for EGFP-GEF-H1
by a-GFP antibody.
(B) GST tagged truncation mutants of GEF-H1 (described in the bottom panel) were expressed in E. coli and purified using glutathione beads. The purified
proteins were then used to pull down Sec5 from lysates of cells expressing HA-Sec5. The pull-downs were analyzed with western blotting.
(C)HA-Sec5was in-vitro-translatedusing rabbit reticulocyte lysate systemandadded to recombinantGSTorGST-GEF-H1 fragmentsdescribed in the lowerpanel.
AssociationbetweenGST-GEF-H1andHA-Sec5wasdeterminedbypullingdownGEF-H1usingglutathionebeadsand thenprobing forSec5usinga-HAantibody.
(D) HA-Sec5was IPed from cell lysates coexpressing Sec5 andGFP-GEF-H1wt or constitutively active, microtubule binding-deficient mutant (GEF-H1C53R), using
a-HA antibody. Coprecipitation of GEF-H1 was analyzed using anti-GFP antibody.
(E)HeLacellswere cotransfectedwithGFP-VSV-GandGST-GEF-H1(aa119-236) orGSTvector and theVSV-Gassaywasdoneasdescribedearlier. Scalebar, 10mm.
(F) Fluorescence intensity associated with 8G5 staining of the samples at time points 60 and 90 min was quantified and expressed relative to that of the cells
transfected with empty vector. More than 40 cells were quantified for each sample and results from three independent experiments are plotted. Data represent
means ± SD. Significance values were calculated using two-tailed Student’s t test (*p < 0.05, **p < 0.005). See also Figure S3.
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tation was observed with GST alone or other regions of GEF-H1.
We next examined whether the binding of GEF-H1 to Sec5 is
dependent on the ability of GEF-H1 to interact with MT. HeLa
cells were cotransfected with HA-Sec5 and either GFP empty
vector, GFP-GEF-H1wt or C53R. HA-Sec5 was immunoprecipi-
tated using HA antibody and assayed for GFP-GEF-H1 interac-
tion. As shown in Figure 5D, the MT binding-deficient GEF-H1
mutant showed high in vivo binding to Sec5 compared to GFP-
GEF-H1wt, while no interaction was observed with GFP empty
vector.
Since depletion of GEF-H1 affects Exo70 localization, we
examined if GEF-H1 and Exo70 might be part of a complex.
We expressed HA-Exo70 in HeLa cells and assayed the lysates
for coprecipitation with recombinant purified truncated versions
of GST-GEF-H1 protein by GST pull-down as described above.
We observed an interaction of Exo70 with the N-terminal region
of GEF-H1 (amino acids between 1 and 236, Figure S3A, lane 2),
the DH and the phospholipid-binding domains (Figure S3A, lanes
3 and 4, respectively) while the C-terminal regions (Figure S3A,
lane 5) and GST protein alone did not precipitate Exo70.
However, we did not detect a direct interaction between in-vi-
tro-translated Exo70 and purified recombinant GST-GEF-H1
(Figure S3B). Since the critical region of GEF-H1 required to
pull down Exo70 in HeLa cells was the same region that bound
directly to Sec5 it is likely that Exo70 interacts with GEF-H1 via
Sec5 or other exocyst components.
Next, we determined if the binding between exocyst and GEF-
H1 contributes to its role in vesicle trafficking. To accomplish
this, we disrupted the interaction between endogenous GEF-
H1 and Sec5 by overexpression of competing GST-GEF-
H1(aa119-236) peptide and examined the effect on secretion of
GFP-VSV-G. As expected, the cells expressing GST-tagged
competing peptide exhibited an accumulation of GFP-VSV-G
vesicles and more than 40% decrease in the insertion of VSV-
G at the PM compared to the GST empty vector (Figures 5E
and 5F). Moreover, we observed that actin cytoskeleton of cells
expressing GST-GEF-H1(aa119-236) peptide or GST empty vector
was not perturbed (Figure S3C). Thus, we conclude that the
direct interaction between GEF-H1 and exocyst protein Sec5 is
crucial for the role of GEF-H1 in membrane trafficking.
Ral GTPases Affect the Interaction betweenGEF-H1 and
Sec5 and the Activation of Rho GTPase
We next determined the molecular mechanism controlling the
interaction between Sec5 and GEF-H1. Ral GTPases have
been shown to regulate the assembly of exocyst complex by
direct interaction with two distinct subunits, Sec5 and Exo84
(Jin et al., 2005; Moskalenko et al., 2002). Since GEF-H1 inter-
acts with Sec5 in vivo, we next examined the effect of RalA
expression on the interaction between endogenous GEF-H1
and Sec5 by immunoprecipitation. As shown in Figures 6A and
6B, overexpression of RalAwt enhanced the interaction between
GEF-H1 and Sec5 by 2-fold compared to the empty vector
control. The effect of constitutively active variant RalA(G23V) and
the fast-cycling activemutant RalA(F39L) was evenmore dramatic
than Ralwt (Figures 6A and 6B; 5- and 6-fold increase in GEF-H1-
Sec5 interaction compared to control, respectively). These data
are consistent with the fact that the fast-cycling mutant blocksDevelopSec5 dimerization facilitating its interaction with other effectors
(Chien et al., 2006). Next, to assess the biological role of RalA-
Sec5-GEF-H1 interaction, we characterized the consequences
on GEF-H1 activity by examining the effect of RalA constructs
on the activation of RhoA using a Rhotekin RBD (Rho-binding
domain) pull-down assay (Stofega et al., 2006). HeLa cells ex-
pressing either empty vector or various constructs of RalA as
mentioned in Figure 6C were treated with DMSO. HeLa cells
treated with Nocodazole were used as positive control for
RhoA activation. We observed a 3-fold increase in the levels of
active RhoA (normalized to total RhoA expression level) in cells
expressing RalAwt or RalAG23V compared to control cells. These
levels were 4-fold higher when cells expressed RalAF39L (Figures
6C and 6D). Intriguingly, RalA mutant (RalAE38R) that cannot
interact with Sec5 was not able to mediate activation of RhoA,
whereas RalAA48W that can bind to Sec5, but not Exo84 (Jin
et al., 2005), facilitated RhoA activation compared to cells with
empty vector (Figures 6C and 6D). This effect of RalA on RhoA
activation was abolished in GEF-H1-depleted cells (Figures 6E
and 6F). These data strongly suggest that RalA promotes the
interaction of Sec5 with GEF-H1 and regulates RhoA activation.
To confirm this, we tested the effect of RalA onRhoA activation in
cells expressing the peptide fragment of GEF-H1 (aa 119–236)
involved in binding with Sec5. We coexpressed GEF-H1(119-236)
or empty vector with either RalG23V or RalF39L in HeLa cells,
then using RBD pull-down assays, we found that cells express-
ing either RalG23V or RalF39L with empty vector increased RhoA
activation by 4-fold and 2-fold, respectively, compared to cells
expressing empty vector alone. Interestingly, cells expressing
RalG23V or RalF39L in presence of GEF-H1(119-236) showed no
enhancement in RhoA activation (Figures 6G and 6H). These
results indicate that RalA mediates RhoA activation via the inter-
action between GEF-H1 and Sec5. Altogether, these results
strongly implicate Ral GTPase in the regulation of the interaction
between Sec5 and GEF-H1 and subsequently in RhoA
activation.
Rho GTPase Regulates Exocyst Assembly and
Localization
Our results prompted us to investigate the role of RhoA in exo-
cyst function. We first determined whether RhoA interacts with
the exocyst complex. We coexpressed in HeLa cells, HA-Sec5
with either GFP-RhoAwt, RhoAQ63L or RhoAT19N. Immunoblot
analyses of Sec5 precipitation and quantification of the data re-
vealed that RhoAwt exhibited a 10-fold higher interaction with
Sec5 as compared to RhoAQ63L and RhoAT19N, suggesting that
the catalytic cycling of RhoA is important for the interaction
(Figures 7A and 7B). Next, we determined whether Rho function
is important for exocyst complex assembly or maintenance by
examining the effect of RhoAwt and variants on the interaction
betweenExo70 andSec8. Immunoblot analysis revealed a signif-
icant increase in the association between Sec8 and Exo70 in the
presence of RhoAwt, but not with RhoAQ63L or RhoAT19N (Figures
7C and 7D). This result indicates that RhoA catalytic cycle plays
a positive role in directing exocyst assembly/maintenance.
Next, we wanted to examine if similar to GEF-H1, RhoA and/or
RhoB influence the localization of exocyst component Exo70.
We depleted RhoA alone or in combination with RhoB, since
RhoB has been shown to compensate for the loss of RhoA (Homental Cell 23, 397–411, August 14, 2012 ª2012 Elsevier Inc. 405
Figure 6. Ral GTPases Regulate Interaction between GEF-H1 and Sec5 and RhoA Activation
(A) Endogenous GEF-H1 was IPed from HeLa cell lysates expressing empty vector, Flag-RalAwt, constitutively active mutant RalAG23V or fast-cycling active
mutant RalAF39L.
(B) The band intensities were quantified and the amount of Sec5 pulled down from each sample was normalized to the levels of immunoprecipitated GEF-H1 and
expressed relative to the sample with empty vector. Data represent means ± SD. Significance values were calculated using two-tailed Student’s t test (*p < 0.05).
(C) GTP-bound active Rho was pulled down from extracts of cells expressing empty vector (EV), RalAwt, RaLAG23V, RalAF39L, Sec5 binding deficient mutant
(E38R), and Exo84 binding deficient mutant (A48W), using Rhotekin-RBD beads (GST tagged Rhotekin-Rho binding domain). The blots were then probed
for RhoA.
(D) The band intensities of GTP-RhoA and total RhoA were quantified. GTP-RhoA was normalized to the total RhoA levels in the lysates and expressed relative to
the control cells with EV. Since enhanced RhoA activation has been reported in response to microtubule depolymerization, nocodazole treatment was used as
a positive control (Chang et al., 2008). Results shown are average of four independent experiments. Data represent means ± SD p values calculated by Student’s
t test, **p < 0.005, ***p < 0.0005.
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of Exo70 by immunofluorescence. As shown in Figure 7E, we
observed a significant increase in the number of cells with accu-
mulation of Exo70-positive vesicles at the periphery in RhoA-
depleted cells compared to control cells. Quantification shown
in Figure 7F revealed that around 50% of RhoA-depleted cells
hadmore than 40 vesicles/cell compared to 11%of control cells.
Simultaneous ablation of both RhoA and B showed only a slight
increase in the accumulation of vesicles compared to RhoA
depletion alone (approximately 60% of double-depleted cells
exhibited >40 vesicles/cell) (Figures 7E and 7F). These data
strongly involve RhoA, in the regulation of the assembly/stability
and localization of the exocyst complex.
As a result of Rho’s involvement in exocyst localization and
assembly, we next investigated the effect of Rho GTPases on
vesicle trafficking by determining the effect of inhibition of Rho
activity on VSV-G transport. As observed by GFP fluorescence
inhibition of RhoA, B and C isoforms by C3 transferase did not
affect the trafficking of VSV-G from ER to Golgi (Figure 7G,
time point 30 min). However, there was a significant decrease
in the insertion of VSV-G at the PM (40%decrease in the intensity
of 8G5 staining compared to control cells) (Figure 7G). Further-
more, we also examined the effect of dominant-negative
RhoA(T19N) or RhoB(T19N) on the incorporation of VSV-G at the
PM (Figures S4A and S4C). VSV-G insertion into the PM revealed
by immunostaining with 8G5 antibody was significantly reduced
by approximately 40% in cells expressing RhoA(T19N) (Figures
S4A and S4B) and by 30% in cells expressing RhoB(T19N) cells
(Figures S4C and S4D) compared to cells with empty vector
(time points 60-90 min). These results further emphasize the
requirement of Rho activity for vesicle targeting. Moreover, since
dominant-negative Rho GTPase mutants sequester the GEFs
and preclude their accessibility to other Rho GTPases, these
results may also emphasize the role of GEF-H1 in the process
of vesicle trafficking.
To identify which isoforms of Rho are required for the vesicle
trafficking, we next depleted RhoA, RhoB, and RhoC individually
or in combination (Figures S5C and S5F) and examined the effect
on VSV-G trafficking to the PM. Incorporation of VSV-G at the
PM was negatively affected by RhoA depletion (approximately
25% reduction in intensity of 8G5 staining compared to control
siRNA cells at 80 and 90 min) and to a larger extent by RhoA
and B codepletion (40%decrease in the intensity of 8G5 staining
compared to control siRNA cells at 80 and 90 min) (Figures 7H
and 7I). Interestingly, depletion of RhoB alone did not show
any effect on VSV-G trafficking to the PM (Figures S5A and
S5B). Since, in RhoA-depleted cells RhoB protein levels increase
considerably (Figure S5C), it can possibly substitute for RhoA’s
function as has been described previously, explaining the
enhanced effect of RhoA and B codepletion on VSV-G trafficking
compared to cells depleted in RhoA alone. Depletion of RhoC(E) EV and active RalA mutants (G23V and F39L) were expressed in control and
using Rhotekin-RBD beads. The blots were probed with a-RhoA antibody.
(F) RhoA activation induced by RalA in presence or absence of GEF-H1 was ex
observed for control or GEF-H1-depleted cells with EV, respectively (number of
(G) Lysates from cells transfected with indicated plasmids were used for RBD pu
(H) The band intensities of GTP-RhoA and total RhoAwere quantified. Rho activati
EV was calculated as described above (number of experiments = 3; data repres
Developindividually did not show any effect on VSV-G trafficking to the
PM (Figures S5A and S5B). Localization of VSV-G at the PM in
cells simultaneously depleted in RhoA, B, and C was similar to
that of RhoA and B codepletion (approximately 40% less stain-
ing with 8G5 antibody at 60 and 90 min compared to control
cells) (Figures S5D and S5E), indicating that RhoC is not involved
in the VSV-G trafficking. Thus, we conclude that RhoA is the
primary Rho GTPase involved in vesicle trafficking to the PM,
while RhoB can substitute partially in absence of RhoA when
RhoB levels are elevated.
DISCUSSION
We have identified a mechanism for RhoA activation and a func-
tion of GEF-H1/RhoA signaling pathway in membrane trafficking
which has important implications for its role in cell division and
migration (Caswell and Norman, 2008; Prekeris and Gould,
2008; Wittmann and Waterman-Storer, 2001). Depletion of
GEF-H1 leads to accumulation of heterogeneous population of
vesicles in cells as observed by DIC as well as thin layer electron
microscopy, suggesting that the structures observed under DIC
are, in fact, vesicles and not membrane blebs. Furthermore,
some of the vesicles colocalized with labeled Tfn, and we
observed defect in both endocytic recycling and exocytosis
(we also observed accumulation of GFP-VSV-G vesicles), sug-
gesting a role for GEF-H1 in the common terminal steps of
vesicle tethering and fusion at the PM. Significant evidence
implicate the exocyst complex as a critical player in targeted
delivery and tethering/fusion of vesicles at the PM.
Our results show that GEF-H1 interacts with exocyst compo-
nents, and is critical for specific localization of Exo70 and Sec8.
GEF-H1 is also involved in the formation of a complex between
the two proteins that, in turn, will have direct impact on the
exocyst complex localization. Depletion of GEF-H1 leads to
accumulation of Exo70-positive vesicles, frequently near the
PM, suggesting a defect in tethering of these vesicles at the
surface. The catalytic activity of GEF-H1 is crucial for its role in
membrane trafficking as the dominant-negative variant of
GEF-H1Y393A exhibited vesicle accumulation similar to GEF-
H1-depleted cells. GEF-H1Y393A expression also leads to a
significant reduction in the association between Sec8 and
Exo70, which is reflected in delay observed in VSV-G exocytosis.
Conversely, constitutively active GEF-H1C53R stimulated the
interaction between the exocyst components and enhanced
exocytosis of VSV-G. GEF-H1C53R also shows stronger interac-
tion with Sec5 than GEF-H1wt suggesting that Sec5 binds more
efficiently to free GEF-H1, and might even facilitate extraction
of GEF-H1 from the MT.
Our results provide strong evidence that RalA stimulates the
interaction between GEF-H1 and Sec5. Furthermore, RalA ex-
pression regulates RhoA activation in Sec5/GEF-H1-dependentGEF-H1-depleted cells. Active RhoA was then pulled down from cell extracts
pressed as percentage of total RhoA in the lysate, and relative to the levels
experiments = 3; data represent means ± SD; *p < 0.05, **p < 0.005).
ll-down.
on for cells expressing indicated proteins relative to the sample transfectedwith
ent means ± SD; p values; *p < 0.05, **p < 0.005).
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Figure 7. Rho GTPase Regulates Exocyst Assembly/Stability and Localization
(A) Sec5 was IPed from cells expressing HA-Sec5 and either GFP-RhoAwt, GFP-RhoAT19N, or GFP-RhoAQ63L. Co-IP of Rho proteins was detected by immu-
noblotting with a-GFP antibody.
(B) The band intensities were quantified and the amount of RhoA associated with Sec5 was normalized to the levels of IPed Sec5. The fold change of interaction
was expressed relative to the RhoAwt sample. n = 3; data represent means ± SD; ***p < 0.0005.
(C) To analyze the effect of Rho mutants on interaction between Sec8 and Exo70, cells were transfected with EV the wild-type, constitutively active
(Q63L) or dominant-negative (T19N) mutants. Sec8 was then IPed using a-Sec8 antibody from the lysates and co-IP with Exo70 was detected using a-Exo70
antibody.
(D) The band intensities from thewestern blots were quantified and the amounts of Exo70 co-IPedwere normalized to the levels of Sec8 pulled down in respective
samples. The fold change in interaction was expressed relative to the sample transfected with EV. Data represent means ± SD. Significance values were
calculated using two-tailed Student’s t test (*p < 0.05).
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family members Rac and Cdc42, but not RhoA through its
effector RLIP76, which acts as a GTPase-activating protein
(Jullien-Flores et al., 1995). Rho GTPase protein level increases
concurrent with Ral activation in response to EGF stimulation
of human tumor cell lines harboring activated HA-RasV12
(Gildea et al., 2002). Now, we have shown that RalA directly
modulates RhoA activity through its effector Sec5.
Rho GTPases play a crucial role in regulating actin dynamics
and membrane trafficking (Ridley, 2001). However, their roles
in regulating vesicle trafficking and fusion at the PM are not
well understood. Evidence from Rho family GTPase TC10 that
regulates exocytosis of GLUT4-containing vesicles suggests
that interaction with exocyst and GTP hydrolysis are important
for exocytic vesicle fusion (Kanzaki and Pessin, 2003; Kawase
et al., 2006). In yeast, Rho GTPases regulate the polarized
localization of exocyst component Sec3, and activation of the
exocyst complex at the PM to facilitate vesicle fusion (Guo
et al., 2001; Wu et al., 2008). Similarly, in mammalian systems
also RhoA may regulate exocyst function for targeting vesicles
to the sites of secretion. Our studies provide evidence that
RhoA activity controls exocyst function by positively affecting
the association between Exo70 and Sec8 and the localization
of Exo70. Therefore, RhoA regulates the Golgi-PM trafficking in
a way similar to what we observed with GEF-H1. It is interesting
to observe that the direct interaction between GEF-H1 and Sec5
is crucial for RhoA activation in response to Ral as well as for
vesicle trafficking without causing observable changes in the
actin cytoskeleton (Figure S3C). Thus, it is likely that GEF-H1
affects membrane trafficking primarily via interaction with
exocyst, although involvement of GEF-H1/Rho pathway in
modulation of actin cytoskeleton might also play some role in
the process of vesicle targeting. Thus, it raises an interesting
possibility that the GEF-H1-Rho signaling pathway can coordi-
nate cytoskeletal modulation with membrane trafficking and
vesicle fusion.
Thus, based on our results, we suggest a model in which a
RalA-exocyst complex facilitates the activation of RhoA by
GEF-H1, for example by localizing delivery of GEF-H1 to specific
sites. RhoA, in turn, regulates exocyst function by affecting its
localized recruitment and/or activation at the PM to facilitate
the complex formation. Our data provide evidence of a mecha-
nism for activation of RhoA by Ral-exocyst-GEF-H1 signaling
event, which, in turn, affects vesicle trafficking via regulation of
exocyst function. We propose GEF-H1 as a key protein that(E) Cells were transfected with control or RhoA and B specific siRNA oligonucle
and visualized using fluorescence microscopy. Scale bar, 10 mm.
(F) Number of Exo70-positive vesicles in control, RhoA-depleted, and RhoA and B
number of vesicles/cell were plotted. More than 50 cells were analyzed from thre
calculated using two-tailed Student’s t test (*p < 0.05, **p < 0.005).
(G) GFP-VSV-G-transfected HeLa cells were treated with cell permeable C3 tr
the fluorescence intensity associated with 8G5 staining of the samples for time p
(no. cells >40; data represent means ± SD; *p < 0.05, **p < 0.005). Scale bar, 10
(H and I) HeLa cells were transfected with 20 nM of RhoA or RhoA+B specific siR
siRNA andGFP-VSV-G for 24 hr. VSV-G trafficking assaywas performed as descri
with 8G5 antibody andmeasuring the intensities at time points 60, 80, and 90min a
More than 50 cells were analyzed for each sample from three separate experime
Data represent means ± SD. Significance values were calculated using two-tail
See also Figures S4 and S5.
Developcan regulate the coordination between MT and actin cytoskel-
eton, and vesicle trafficking.
EXPERIMENTAL PROCEDURES
Electron Microscopy
HeLa cells plated on plastic bottom dishes were transfected with 20 nM
control siRNA or GEF-H1 siRNA using Lipofectamine RNAi Max (Invitrogen).
Seventy-two hours posttransfection, cells were processed using the
Gilula et al. method (Gilula et al., 1978) (see Supplemental Experimental
Procedures for details).
Tfn Internalization and Recycling Assays
HeLa cells transfected with control or GEF-H1-specific siRNA were plated on
fibronectin (FN)-coated glass coverslips after 48 hr. Next day, the cells
were serum starved for 2 hr before incubating them in medium containing
15 mg/ml Alexa Fluor 568-conjugated Tfn (Molecular Probes, Eugene, OR)
for 10 min at 37C. The cells were then washed with PBS and incubated in
acid stripping buffer (0.2 M acetic acid, 0.5 M NaCl [pH 2.8]) for 2 min on ice
to remove surface bound ligand. Samples were then neutralized by washing
with PBS and fixedwith 4%paraformaldehyde (PFA), mounted on glass slides,
and observed under fluorescence microscope. The kinetics of Tfn uptake was
measured after 72 hr of GEF-H1 depletion by using biotinylated Tfn as
described earlier (Sever et al., 2000). Briefly, cells were detached using
5 mM EDTA in PBS buffer and incubating at 37C for 5 min. Cells were then
washed briefly with PBS and resuspended in ice-cold buffer containing
1 mM MgCl2, 1 mM CaCl2, 0.2% BSA, 5 mM glucose, and 5 mg/ml biotiny-
lated-Tfn (Molecular Probes) at density of 23 106 cells/ml. Cells were then split
into 50 ml aliquots on ice and internalization of Tfn was triggered by incubating
the samples in 37C water bath for appropriate time intervals. The samples for
time point 0 min and ‘‘total Tfn’’ (indicating the total amount of labeled-Tfn
bound to the cells) were kept on ice for the duration of the experiment. Inter-
nalization of Tfn was stopped by transferring the samples to ice, which stops
endocytosis. The samples, including time point 0 min were washed once with
cold PBS and resuspended in 100 ml of PBS containing 0.2% BSA and 50 mg/
ml avidin (Sigma) and then incubated on a tube shaker for 1 hr at 4C to mask
the surface-bound Tfn. The reaction was then quenched by the addition of
10 ml of 0.5 mg/ml biocytin (Sigma) and incubated again for 10 min at 4C on
tube shaker. All the samples including ‘‘total Tfn’’ were solubilized by addition
of blocking buffer (2.9 mg/ml NaCl, 1.6 mg/ml Tris-HCl (pH 7.6), 3.7 mg/ml
EDTA, final pH 7.4) and vortexing. After incubating on ice for 5–10 min the
samples were transferred to ELISA plates coated with a-Tfn antibody (whole
serum produced in goat, Sigma). The plates were incubated overnight at
4C. The wells were then washed three times with PBS and developed using
200 ml assay buffer (10 mg o-phenylenediamine, 10 ml of 30% H2O2 in 25 ml
of citrate buffer containing 50 mM Na2HPO4, 27 mM citrate [pH 5]) and incu-
bating at room temperature to develop color, for approximately 2–4 min.
This reaction was terminated by the addition of 50 ml 2M H2SO4 per well.
The absorbance was measured at 490 nm and corrected for 650 nm. The
amount of Tfn internalized at different time points was expressed as
percentage of total Tfn bound to the cells.otides for 48 hr. Cells were then fixed, immunostained with a-Exo70 antibody
codepleted cells were counted and percentage of cells carrying the indicated
e separate experiments. Data represent means ± SD. Significance values were
ansferase for 4 hr before performing the trafficking assay. Quantification of
oints 60, 80, and 90 min was expressed relative to that of the untreated cells
mm.
NA oligonucleotides for 48 hr. Then cells were transfected again with 20 nM of
bed inmethods. VSV-G insertion into the PMwas assessed by staining the cells
nd expressing the values relative to that of the control siRNA-transfected cells.
nts.
ed Student’s t test (*p < 0.05, **p < 0.005, ***p < 0.0005). Scale bar = 10mm.
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fluorescencemicroscopy, instead of biotinylated-Tfn due to difficulties associ-
ated with incubating the cells at 4C for prolonged periods of time for masking
the surface bound biotinylated-Tfn with avidin. GEF-H1-depleted and control
cells were plated on glass coverslips and serum starved for 2 hr. Samples
were then incubated with 15 mg/ml of fluorescently labeled Tfn for 1 hr at
37C. The samples were then washed with PBS and fresh medium containing
15 mg/ml unlabeled Tfn (Sigma) was added to drive the Tfn recycling process,
and incubated at 37C. Samples were taken out at indicated time points, acid
washed to remove surface-bound ligand, fixed with PFA, and observed using
fluorescence microscope. Amount of Tfn retained within the cells at various
time points was quantified and expressed as the percentage of total internal-
ized Tfn at t = 0. The rate of decay was determined by fitting the natural log
of the ratio of average fluorescence intensity of Tfn retained within the cells
at time t over the average fluorescence intensity at the start of the experiment
to a linear dependence on time. The slope is the rate of decay. The half-life was
calculated as the natural log of 2 divided by the rate of decay.
Exocytosis Assays
siRNA-transfected cells were plated on FN-coated glass coverslips after 48 hr.
Cells were then transfected with GFP-VSV-Gts045 and incubated further for
20 hr at 40C. For analysis of the effect of GEF-H1 overexpression on exocy-
tosis, WT and variants of GEF-H1 were cotransfected with GFP-VSV-Gts045 for
20 hr. All subsequent incubations at the permissive temperature (32C) were
done in the presence of 50 mg/ml cycloheximide (Sigma) to halt protein
synthesis. After taking a sample at t = 0 the cells were shifted to 32C and
samples were taken at indicated time points and fixed with 4% PFA. Cells
were stained with mouse monoclonal anti-VSV-G (8G5) antibody without
permeabilization to visualize the insertion of VSV-G in the PM. Trafficking of
VSV-G through ER to the PM was visualized using GFP fluorescence. The
samples were observed using confocal microscope.
In Vitro Translation and Binding Assay
To determine whether the binding between GEF-H1 and Sec5 or Exo70 was
direct, recombinant GST-GEF-H1 fragments spanning the entire sequence
of GEF-H1 were used. HA-rSec5 and HA-rExo70 were in-vitro-translated
(Promega TNT Quick Coupled) for 90 min at 30C. 12 ml was used in each
binding reaction. Extracts were incubated in binding buffer containing
50 mM Tris (pH 7.4), 150 mM NaCl, and 1.0% NP-40 for 2 hr at 4C. Samples
were washed 3x in binding buffer and resolved by SDS-PAGE gel and immu-
noblotted with anti-HA antibody.
Pull-Down Assay
Cells transfected with appropriate plasmids were lysed and RBD pull-down
assay was performed as described earlier (Stofega et al., 2006). For nocoda-
zole (Sigma-Aldrich, St. Louis, MO) treatment, cells were incubated with either
DMSO or 10 mM nocodazole for 45 min at 37C.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
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http://dx.doi.org/10.1016/j.devcel.2012.06.014.
ACKNOWLEDGMENTS
We dedicate this manuscript to the memory of late Dr. Gary Bokoch, without
whose support and guidance this work would not have been possible. We
thank Charles Yeaman, Rytis Prekeris, Jennifer Lippincott-Schwartz, Klaus
Hahn, and Douglas Lyles for some of the reagents used in this study. We
also thank Charles Yeaman for helpful suggestions and advice and Bruce
Fowler for assistance with preparation of some DNA constructs. This study
was supported by an NIH grant to G.M.B. and C.D.M. (GM39434).
Received: October 15, 2010
Revised: May 23, 2012
Accepted: June 2, 2012
Published online: August 13, 2012410 Developmental Cell 23, 397–411, August 14, 2012 ª2012 ElsevieREFERENCES
Birkenfeld, J., Nalbant, P., Bohl, B.P., Pertz, O., Hahn, K.M., and Bokoch, G.M.
(2007). GEF-H1 modulates localized RhoA activation during cytokinesis under
the control of mitotic kinases. Dev. Cell 12, 699–712.
Birkenfeld, J., Nalbant, P., Yoon, S.H., and Bokoch, G.M. (2008). Cellular func-
tions of GEF-H1, a microtubule-regulated Rho-GEF, is altered GEF-H1 activity
a crucial determinant of disease pathogenesis? Trends Cell Biol. 18, 210–219.
Boyd, C., Hughes, T., Pypaert, M., and Novick, P. (2004). Vesicles carry most
exocyst subunits to exocytic sites marked by the remaining two subunits,
Sec3p and Exo70p. J. Cell Biol. 167, 889–901.
Caswell, P., and Norman, J. (2008). Endocytic transport of integrins during cell
migration and invasion. Trends Cell Biol. 18, 257–263.
Chang, Y.C., Nalbant, P., Birkenfeld, J., Chang, Z.F., and Bokoch, G.M. (2008).
GEF-H1 couples nocodazole-induced microtubule disassembly to cell
contractility via RhoA. Mol. Biol. Cell 19, 2147–2153.
Chien, Y., Kim, S., Bumeister, R., Loo, Y.M., Kwon, S.W., Johnson, C.L.,
Balakireva, M.G., Romeo, Y., Kopelovich, L., Gale, M., Jr., et al. (2006). RalB
GTPase-mediated activation of the IkappaB family kinase TBK1 couples
innate immune signaling to tumor cell survival. Cell 127, 157–170.
Feng, Y., Press, B., and Wandinger-Ness, A. (1995). Rab 7: an important regu-
lator of late endocytic membrane traffic. J. Cell Biol. 131, 1435–1452.
Fielding, A.B., Schonteich, E., Matheson, J., Wilson, G., Yu, X., Hickson, G.R.,
Srivastava, S., Baldwin, S.A., Prekeris, R., and Gould, G.W. (2005). Rab11-
FIP3 and FIP4 interact with Arf6 and the exocyst to control membrane traffic
in cytokinesis. EMBO J. 24, 3389–3399.
Gildea, J.J., Harding, M.A., Seraj, M.J., Gulding, K.M., and Theodorescu, D.
(2002). The role of Ral A in epidermal growth factor receptor-regulated cell
motility. Cancer Res. 62, 982–985.
Gilula, N.B., Epstein, M.L., and Beers, W.H. (1978). Cell-to-cell communication
and ovulation. A study of the cumulus-oocyte complex. J. Cell Biol. 78, 58–75.
Gromley, A., Yeaman, C., Rosa, J., Redick, S., Chen, C.T., Mirabelle, S., Guha,
M., Sillibourne, J., andDoxsey, S.J. (2005). Centriolin anchoring of exocyst and
SNARE complexes at the midbody is required for secretory-vesicle-mediated
abscission. Cell 123, 75–87.
Guo, W., Sacher, M., Barrowman, J., Ferro-Novick, S., and Novick, P. (2000).
Protein complexes in transport vesicle targeting. Trends Cell Biol. 10,
251–255.
Guo, W., Tamanoi, F., and Novick, P. (2001). Spatial regulation of the exocyst
complex by Rho1 GTPase. Nat. Cell Biol. 3, 353–360.
He, B., andGuo,W. (2009). The exocyst complex in polarized exocytosis. Curr.
Opin. Cell Biol. 21, 537–542.
Hirschberg, K., Miller, C.M., Ellenberg, J., Presley, J.F., Siggia, E.D., Phair,
R.D., and Lippincott-Schwartz, J. (1998). Kinetic analysis of secretory protein
traffic and characterization of golgi to plasma membrane transport intermedi-
ates in living cells. J. Cell Biol. 143, 1485–1503.
Ho, T.T., Merajver, S.D., Lapie`re, C.M., Nusgens, B.V., and Deroanne, C.F.
(2008). RhoA-GDP regulates RhoB protein stability. Potential involvement of
RhoGDIalpha. J. Biol. Chem. 283, 21588–21598.
Jin, R., Junutula, J.R., Matern, H.T., Ervin, K.E., Scheller, R.H., and Brunger,
A.T. (2005). Exo84 and Sec5 are competitive regulatory Sec6/8 effectors to
the RalA GTPase. EMBO J. 24, 2064–2074.
Jullien-Flores, V., Dorseuil, O., Romero, F., Letourneur, F., Saragosti, S.,
Berger, R., Tavitian, A., Gacon, G., and Camonis, J.H. (1995). Bridging Ral
GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-
activating protein activity. J. Biol. Chem. 270, 22473–22477.
Kanzaki, M., and Pessin, J.E. (2003). Insulin signaling: GLUT4 vesicles exit via
the exocyst. Curr. Biol. 13, R574–R576.
Kawase, K., Nakamura, T., Takaya, A., Aoki, K., Namikawa, K., Kiyama, H.,
Inagaki, S., Takemoto, H., Saltiel, A.R., and Matsuda, M. (2006). GTP hydro-
lysis by the Rho family GTPase TC10 promotes exocytic vesicle fusion. Dev.
Cell 11, 411–421.
Kornfeld, S., and Mellman, I. (1989). The biogenesis of lysosomes. Annu. Rev.
Cell Biol. 5, 483–525.r Inc.
Developmental Cell
GEF-H1 Regulates Vesicle Trafficking via ExocystKrendel, M., Zenke, F.T., and Bokoch, G.M. (2002). Nucleotide exchange
factor GEF-H1 mediates cross-talk between microtubules and the actin
cytoskeleton. Nat. Cell Biol. 4, 294–301.
Lefrancois, L., and Lyles, D.S. (1982). The interaction of antibody with the
major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal
antibodies of nonneutralizing and cross-reactive epitopes of Indiana and
New Jersey serotypes. Virology 121, 168–174.
Liu, J., Zuo, X., Yue, P., and Guo, W. (2007). Phosphatidylinositol 4,5-bisphos-
phate mediates the targeting of the exocyst to the plasma membrane for
exocytosis in mammalian cells. Mol. Biol. Cell 18, 4483–4492.
Maxfield, F.R., and McGraw, T.E. (2004). Endocytic recycling. Nat. Rev. Mol.
Cell Biol. 5, 121–132.
Mellman, I. (1996). Endocytosis and molecular sorting. Annu. Rev. Cell Dev.
Biol. 12, 575–625.
Montagnac, G., Echard, A., and Chavrier, P. (2008). Endocytic traffic in animal
cell cytokinesis. Curr. Opin. Cell Biol. 20, 454–461.
Moskalenko, S., Henry, D.O., Rosse, C., Mirey, G., Camonis, J.H., and White,
M.A. (2002). The exocyst is a Ral effector complex. Nat. Cell Biol. 4, 66–72.
Nalbant, P., Chang, Y.C., Birkenfeld, J., Chang, Z.F., and Bokoch, G.M. (2009).
Guanine nucleotide exchange factor-H1 regulates cell migration via localized
activation of RhoA at the leading edge. Mol. Biol. Cell 20, 4070–4082.
Novick, P., and Guo, W. (2002). Ras family therapy: Rab, Rho and Ral talk to
the exocyst. Trends Cell Biol. 12, 247–249.
Oztan, A., Silvis, M., Weisz, O.A., Bradbury, N.A., Hsu, S.C., Goldenring, J.R.,
Yeaman, C., and Apodaca, G. (2007). Exocyst requirement for endocytic traffic
directed toward the apical and basolateral poles of polarizedMDCK cells. Mol.
Biol. Cell 18, 3978–3992.
Prekeris, R., and Gould, G.W. (2008). Breaking up is hard to do - membrane
traffic in cytokinesis. J. Cell Sci. 121, 1569–1576.DevelopPrigent, M., Dubois, T., Raposo, G., Derrien, V., Tenza, D., Rosse´, C., Camonis,
J., and Chavrier, P. (2003). ARF6 controls post-endocytic recycling through its
downstream exocyst complex effector. J. Cell Biol. 163, 1111–1121.
Ren, Y., Li, R., Zheng, Y., and Busch, H. (1998). Cloning and characterization of
GEF-H1, a microtubule-associated guanine nucleotide exchange factor for
Rac and Rho GTPases. J. Biol. Chem. 273, 34954–34960.
Ridley, A.J. (2001). Rho proteins: linking signaling with membrane trafficking.
Traffic 2, 303–310.
Sever, S., Damke, H., and Schmid, S.L. (2000). Dynamin:GTP controls the
formation of constricted coated pits, the rate limiting step in clathrin-mediated
endocytosis. J. Cell Biol. 150, 1137–1148.
Stenmark, H., Aasland, R., Toh, B.H., and D’Arrigo, A. (1996). Endosomal
localization of the autoantigen EEA1 ismediated by a zinc-binding FYVE finger.
J. Biol. Chem. 271, 24048–24054.
Stofega, M., DerMardirossian, C., and Bokoch, G.M. (2006). Affinity-based
assay of Rho guanosine triphosphatase activation. Methods Mol. Biol. 332,
269–279.
Ullrich, O., Reinsch, S., Urbe´, S., Zerial, M., and Parton, R.G. (1996). Rab11
regulates recycling through the pericentriolar recycling endosome. J. Cell
Biol. 135, 913–924.
Urbe´, S., Huber, L.A., Zerial, M., Tooze, S.A., and Parton, R.G. (1993). Rab11,
a small GTPase associated with both constitutive and regulated secretory
pathways in PC12 cells. FEBS Lett. 334, 175–182.
Wittmann, T., and Waterman-Storer, C.M. (2001). Cell motility: can Rho
GTPases and microtubules point the way? J. Cell Sci. 114, 3795–3803.
Wu, H., Rossi, G., and Brennwald, P. (2008). The ghost in the machine: small
GTPases as spatial regulators of exocytosis. Trends Cell Biol. 18, 397–404.mental Cell 23, 397–411, August 14, 2012 ª2012 Elsevier Inc. 411
